Close
Novotech
Jabsco PureFlo 21 Single Use

News

DoKaSch Temperature Solutions expands its business in India

The Indian pharmaceutical industry worldwide ranks third in pharmaceutical production by volume, according to the Indian government. In order to position itself even better in this region, DoKaSch Temperature Solutions has announced James Savio as Business Development Manager India. “I...

Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites

Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites. The company’s investment in these new state-of-the-art manufacturing facilities will allow them...

Bora merges with Sunway Biotech to launch global Nutraceuticals offering

Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its merged with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization. Resulting in...

Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth

Mural Health Technologies, Inc. a next-generation clinical trial participant management platform announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures, and Project...

Accelerating Drug Development Through CDMO Partnerships

Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics is anticipated to reach around $53 billion worldwide in the same year. Two predominant trends currently...

Prefilled Syringes Market Surges To $18.43 Billion In 2023

The global market for prefilled syringes reached a value of USD 18.43 billion in 2023 and is expected to experience a compound annual growth rate (CAGR) of 11.95% from 2023 to 2030. This growth is primarily fueled by the...

Takeda Reiterates the Need of Equitable Access to Healthcare for Universal Impact

Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Pvt Ltd) – a global values-based, R&D-driven biopharmaceutical leader in innovative healthcare solutions presented an industry perspective on equitable access to healthcare during the 5th edition of the Confederation of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »